Update on Strongyloidiasis in the Immunocompromised Host
- 1 December 2010
- journal article
- Published by Springer Science and Business Media LLC in Current Infectious Disease Reports
- Vol. 13 (1), 35-46
- https://doi.org/10.1007/s11908-010-0150-z
Abstract
Immunocompromised persons are the most vulnerable population at risk for developing life-threatening clinical syndromes associated with strongyloidiasis, such as hyperinfection syndrome (HS) or dissemination. This review focuses on describing Strongyloides infection in the immunocompromised host, including immune response against this infection, analyzing the cases with HS published during the past 4 years in the United States, and describing the most sensitive diagnostic tools and the most effective treatment for each clinical syndrome. Strongyloidiasis is becoming an important parasitic disease in the United States, especially in the immunocompromised immigrant population. Because the transplant population is particularly at risk for developing HS, both recipients and donors should be screened for Strongyloides. Clinicians should also be aware that the development of HS can follow unexpectedly a few days after appropriate anthelminthic therapy. Highly sensitive screening tests are still not available in the major tertiary medical centers. Parenteral ivermectin has been used in some severe cases. Further therapy developments and improving diagnostic tools are warranted.Keywords
This publication has 114 references indexed in Scilit:
- Strongyloidiasis-Related Deaths in the United States, 1991–2006The American Journal of Tropical Medicine and Hygiene, 2010
- Strongyloidiasis in Transplant PatientsClinical Infectious Diseases, 2009
- Intestinal parasitic infections in relation to HIV/AIDS status, diarrhea and CD4 T-cell countBMC Infectious Diseases, 2009
- Fatal Outcome of Disseminated Strongyloidiasis despite Detectable Plasma and Cerebrospinal Levels of Orally Administered IvermectinJournal of Parasitology Research, 2009
- Immunological Responses Elicited by Different Infection Regimes with Strongyloides rattiPLOS ONE, 2008
- Dissemination of Strongyloides stercoralis in a patient with systemic lupus erythematosus after initiation of albendazole: a case reportJournal of Medical Case Reports, 2008
- Density-dependent immune responses against the gastrointestinal nematode Strongyloides rattiInternational Journal for Parasitology, 2007
- A Canadian immigrant with coinfection of Strongyloides stercoralis and human T-lymphotropic virus 1CMAJ : Canadian Medical Association Journal, 2007
- Effect of treatment of Strongyloides infection on HTLV‐1 expression in a patient with adult T‐cell leukemiaAmerican Journal of Hematology, 2007
- The immune response during a Strongyloides ratti infection of ratsParasite Immunology, 2007